Spots Global Cancer Trial Database for experimental arm
Every month we try and update this database with for experimental arm cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no More Than Three Residual Metastatic Lesions Following First Line Systemic Therapy | NCT04428554 | Urothelial Blad... | Experimental ar... | 18 Years - | Institut Claudius Regaud | |
| FOLFOXIRI With or Without Intensification for Rectal Cancer | NCT03997435 | Rectal Cancer | Control arm Experimental ar... | 18 Years - | Chinese University of Hong Kong | |
| Stereotactic Ablative Radiotherapy for Oligo-Progressive Disease REfractory to Systemic Therapy in Metastatic Cancer | NCT04989725 | Head and Neck C... Metastatic Canc... Oligoprogressiv... | Standard arm Experimental ar... | 18 Years - | Centre hospitalier de l'Université de Montréal (CHUM) | |
| Prognostic and Predictive Value of HE4 Biomarker in Metastatic Ovarian Cancer | NCT01768156 | Metastatic Ovar... | Experimental ar... | 18 Years - | Institut du Cancer de Montpellier - Val d'Aurelle | |
| Stereotactic Ablative Radiotherapy for Oligo-Progressive Disease REfractory to Systemic Therapy in Metastatic Cancer | NCT04989725 | Head and Neck C... Metastatic Canc... Oligoprogressiv... | Standard arm Experimental ar... | 18 Years - | Centre hospitalier de l'Université de Montréal (CHUM) | |
| A Comparative Study of Pravastatin vs Placebo as Primary Prevention of Severe Subcutaneous Breast Fibrosis in Hyper-radiosensitive Identified Patients With Breast Cancer | NCT04385433 | Breast Cancer | EXPERIMENTAL AR... CONTROL GROUP Standard adjuva... | 18 Years - | Institut du Cancer de Montpellier - Val d'Aurelle | |
| Phase III Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of Glioblastoma | NCT01507506 | Glioblastoma | Radiotherapy Experimental ar... | 18 Years - | Institut Claudius Regaud | |
| HE4 as a Relapse Biomarker in Ovarian Cancers | NCT02595281 | Ovarian Carcino... | Experimental ar... | 18 Years - | Institut de Cancérologie de Lorraine | |
| Radiation Dose Optimization in Diffuse Large B- Cell Lymphoma. | NCT02964858 | NonHodgkin Lymp... | Standard Arm Experimental Ar... | 18 Years - 65 Years | Tata Memorial Hospital | |
| Radiation Dose Optimization in Diffuse Large B- Cell Lymphoma. | NCT02964858 | NonHodgkin Lymp... | Standard Arm Experimental Ar... | 18 Years - 65 Years | Tata Memorial Hospital | |
| A Comparative Study of Pravastatin vs Placebo as Primary Prevention of Severe Subcutaneous Breast Fibrosis in Hyper-radiosensitive Identified Patients With Breast Cancer | NCT04385433 | Breast Cancer | EXPERIMENTAL AR... CONTROL GROUP Standard adjuva... | 18 Years - | Institut du Cancer de Montpellier - Val d'Aurelle | |
| Smoking Tobacco Cessation Integrated Program of Patients Treated for the Head and the Neck Cancer | NCT03788785 | Carcinoma, Squa... Tobacco Use Dis... | Experimental ar... Control arm | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| HE4 as a Relapse Biomarker in Ovarian Cancers | NCT02595281 | Ovarian Carcino... | Experimental ar... | 18 Years - | Institut de Cancérologie de Lorraine | |
| PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer | NCT05581121 | Cervical Carcin... Adenocarcinoma Adenosquamous C... | Standard treatm... Experimental ar... | 18 Years - | Institut Claudius Regaud | |
| FOLFOXIRI With or Without Intensification for Rectal Cancer | NCT03997435 | Rectal Cancer | Control arm Experimental ar... | 18 Years - | Chinese University of Hong Kong | |
| Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no More Than Three Residual Metastatic Lesions Following First Line Systemic Therapy | NCT04428554 | Urothelial Blad... | Experimental ar... | 18 Years - | Institut Claudius Regaud |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
